Device / Technology News

RSS

Tenfold increase in OARnet network bandwidth speeds will boost medical research

Following his State of the State announcement of a tenfold boost to OARnet's statewide network bandwidth, Governor John R. Kasich joined medical researchers from across the state on Feb. 27 in a video teleconference to discuss how the faster network speeds will help enhance innovation.

29 Feb 2012

Positive reaction from hospitals, consumer groups on 'stage 2' health IT rules

Both hospital and consumer groups are reacting positively to new federal rules meant to improve the effective use of the technology, and new electronic health records certification rules are released.

29 Feb 2012

UVA, Johns Hopkins receive NIH grant to develop methods against glioblastoma

The most common primary brain cancer is glioblastoma, a highly aggressive and deadly form of tumor that kills about 95 percent of its victims within five years of diagnosis. Like other brain cancers, it is extremely difficult to treat because glioblastomas are usually deeply embedded within healthy brain tissue and therefore nearly impossible to safely access. Chemotherapy drugs cannot reach these tumors because a membrane between the bloodstream and brain tissue, called the blood-brain barrier, blocks them.

29 Feb 2012

Simple and accurate device to study malaria

University of British Columbia researcher Hongshen Ma has developed a simple and accurate device to study malaria, a disease that currently affects 500 million people per year worldwide and claims a million lives.

29 Feb 2012

Shire, arGEN-X partner to create novel antibodies against rare diseases

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.

29 Feb 2012

Positive results from Critical Diagnostics' biomarker study in ambulatory heart failure patients

Critical Diagnostics, a biomarker company focused on cardiovascular diseases, today announced positive results from a multi-center study in ambulatory heart failure patients, which confirmed that a contemporary panel of biomarkers, including ST2, was strongly predictive of risk and significantly improved the likelihood of identifying patients at risk for adverse events, compared to the most commonly used clinical risk score in heart failure, the Seattle Heart Failure Model.

29 Feb 2012

Mantra-based meditation shows promise against age-associated cognitive impairment

Researchers at Thomas Jefferson University Hospital determined that mantra-based meditation can have a positive impact on emotional responses to stress, fatigue and anxiety in adults with memory impairment and memory loss.

29 Feb 2012

Quitting hormone therapy can lead to breast tumor regression

As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Biomarkers, & Prevention.

29 Feb 2012

PRI introduces OnSite to assist clinical sites with patient enrollment solutions

Patient Recruiters International, Inc. (PRI), a leading provider of direct patient access solutions for patient recruitment, announced today the launch of OnSite.

29 Feb 2012

Genome sequencing helps characterize S. aureus ST398-NM strain

Using genome sequencing and household surveillance, National Institutes of Health (NIH) scientists and their colleagues from Columbia University Medical Center and St. George's University of London have pieced together how a newly emerging type of Staphylococcus aureus bacteria has adapted to transmit more easily among humans.

29 Feb 2012

TUT creates first biodegradable joint implant for arthritic patients

Tampere University of Technology (TUT), Finland, has been the first in the world to develop biodegradable joint implant, RegJoint-. The implant is used in the treatment of osteoarthritis and rheumatoid arthritis.

29 Feb 2012

Activating brain's visual cortex improves our sense of smell

A new study reveals for the first time that activating the brain's visual cortex with a small amount of electrical stimulation actually improves our sense of smell.

28 Feb 2012

BrainAble project to offer benefits for people with motor disabilities

In the 2009 film Surrogates, humans live vicariously through robots while safely remaining in their own homes. That sci-fi future is still a long way off, but recent advances in technology, supported by EU funding, are bringing this technology a step closer to reality in order to give disabled people more autonomy and independence than ever before.

28 Feb 2012

Biogen Idec receives FDA approval for two separate dosing innovations to treat MS

Today Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved two separate dosing innovations designed to improve the treatment experience for patients receiving once-a-week AVONEX for relapsing forms of multiple sclerosis (MS).

28 Feb 2012

New guidelines for detection of rheumatic heart disease

The inaugural international guidelines for the diagnosis of rheumatic heart disease (RHD), a disease that affects tens of millions of people worldwide, have today been published by the World Heart Federation in Nature Reviews Cardiology.

28 Feb 2012

Lantronix selects ADI's iCoupler technology to enable new wireless communication devices

Analog Devices, Inc. (ADI) today announced that Lantronix, Inc. has selected ADI's iCoupler digital isolator technology to enable its new family of wireless communication network servers.

28 Feb 2012

Journal of Cardiac Failure explains new recommendations for CRT use

Based on a review of the latest evidence, the Guidelines Committee of the Heart Failure Society of America now recommends that the use of cardiac resynchronization therapy (CRT) be expanded to a larger group of patients with mild heart failure symptoms.

28 Feb 2012

Largest study to date to observe dynamic social scenes in children with ASD

In a study published in the March 2012 issue of the Journal of the American Academy of Child and Adolescent Psychiatry, Katherine Rice and colleagues, from the Marcus Autism Center, Children's Healthcare of Atlanta, and Emory University School of Medicine, used eye-tracking technology to measure the relationship between cognitive and social disability in children with autism spectrum disorders (ASD) and the ability of children with ASD to pay attention to social interactions.

28 Feb 2012

FDA panel schedules review for U-Systems' somo•v ABUS system

U-Systems, the leader in automated breast ultrasound, today announced the somo•v Automated Breast Ultrasound (ABUS) system has been scheduled for review by the Radiological Devices Panel of the U.S. Food & Drug Administration (FDA) on April 11, 2012.

28 Feb 2012

Rapid influenza diagnostic tests highly accurate in children than in adults

A new study conducted by researchers from McGill University, the Research Institute of the McGill University Health Centre (RI MUHC), and Sainte-Justine University Hospital Research Centre, Montreal, has put the accuracy of rapid influenza diagnostic tests (RIDTs) under the microscope.

28 Feb 2012